| Beacon Pharmaceuticals Limited IPO Lottery | | | | life of patients across the world. |
| Result (2010) | | | | Beacon means the light which serves as guide. It |
| Beacon Pharmaceuticals Limited IPO Lottery | | | | helps ocean going vessels to find ways during the |
| Result will be published as soon as possible after | | | | darkness of night. Beacon Pharmaceuticals Ltd. |
| the lottery draw. | | | | with its world class products and services will act |
| Beacon Pharmaceuticals Limited IPO Lottery date | | | | as a light for saving lives from life threatening |
| Here: | | | | conditions like cancer, heart, liver, kindey and |
| Beacon Pharmaceuticals Limited IPO Lottery | | | | other diseases. It will show the ray of light to ailing |
| Result will be available soon after the lottery draw | | | | patients to live a healthy longer life in this beautiful |
| Beacon Pharmaceuticals Limited IPO Lottery | | | | world. Beacon stands for light for life. |
| Result Details, | | | | Beacon Pharmaceuticals Limited |
| Beacon Pharmaceuticals Limited IPO Lottery | | | | Beacon Pharmaceuticals Limited Nature of |
| Result Bank code and RAK Beacon | | | | Business: |
| Pharmaceuticals Limited IPO Lottery refund | | | | The Company is engaged in manufacturing |
| warrant date and RAK Beacon Pharmaceuticals | | | | andmarketing of pharmaceuticals finished |
| Limited IPO allotment date and location. | | | | Formulation Products and life saving Intravenous |
| Beacon Pharmaceuticals Limited IPO Lottery | | | | (I.V) Fluids, hitechlyophilized anticancer drugs, |
| Result : Bank / Branch Code | | | | Active Pharmaceuticals Ingredients (APIs), |
| Beacon Pharmaceuticals Limited IPO Lottery | | | | Bio-tech products & Genetic Engineering |
| Result : Other than NRB (General Public) | | | | products which it sells in the local markets. The |
| Beacon Pharmaceuticals Limited IPO Lottery | | | | Company also provides contract manufacturing |
| Result : Mutual Fund | | | | and tool manufacturing services. |
| Beacon Pharmaceuticals Limited IPO Lottery | | | | Beacon Pharmaceuticals Limited Subscription Open |
| Result : Non - Resident Bangladeshi (NRB) | | | | : June 20, 2010 |
| Beacon Pharmaceuticals Limited IPO : Distribution | | | | Beacon Pharmaceuticals Limited Subscription Close |
| of Refund Warrantso please visit here to know | | | | : June 24, 2010 |
| Beacon Pharmaceuticals Limited IPO Lottery | | | | Beacon Pharmaceuticals Limited For Non-Resident |
| Result | | | | Bangladeshi June 20, 2010 to July 03, 2010 |
| Beacon Pharmaceuticals Limited IPO Lottery | | | | Beacon Pharmaceuticals Limited Reason for IPO |
| Result will be pulished ASAP after the lottery | | | | To meet the working capital requirement. |
| draw. | | | | Beacon Pharmaceuticals Limited Offer Price Per |
| Based in Bangladesh Beacon Pharmaceuticals Ltd. | | | | Share Tk. 10.00 |
| is one of the finest pharmaceuticals manufacturing | | | | Beacon Pharmaceuticals Limited Face Value Per |
| facilities to be found any where in the world. It is | | | | Share Tk. 10.00 |
| a centrally monitored fully automated plant with | | | | Beacon Pharmaceuticals Limited Market Lot |
| the help of integrated Building Management | | | | (Shares) : 500 |
| System (BMS) of USA . Spread over a huge 15 | | | | Beacon Pharmaceuticals Limited Pre-IPO Paid-up |
| acres of land and having more than 150,000 sft | | | | Capital : Tk. |
| covered areas, the US $ 30 million manufacturing | | | | 1,900,000,000.00 |
| complex has been designed by a reputed | | | | Beacon Pharmaceuticals Limited Public Offer |
| European pharmaceuticals consultant. The facilities | | | | (Shares): 30,000,000 |
| have been created in order to comply international | | | | Beacon Pharmaceuticals Limited Total Issued |
| regulatory requirements like FDA - USA, MHRA - | | | | Shares (after IPO) : 220,000,000 |
| UK, TGA - Australia and GMP - WHO. Backed by | | | | Beacon Pharmaceuticals Limited Total Paid-up |
| a strong R&D set-up Beacon will | | | | Capital (after IPO) Tk. 2,200,000,000.00 |
| manufacture specialized drugs in therapy areas | | | | Beacon Pharmaceuticals Limited EPS (as per |
| like Cancer diseases, Hormone therapies, | | | | Prospectus) Tk. 0.31 (as on 30.06.2009) |
| Cardio-vascular and chronic care diseases. With its | | | | Beacon Pharmaceuticals Limited NAV Per Share |
| cutting edge state-of -the-art facilitiesBeacon is | | | | (after revaluation;as per Prospectus) : Tk.16.05 (as |
| committed to improve the health and quality of | | | | on 30.06. |